Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms.

Arthritis and rheumatism - 15 Oct 2009

Okada Satoshi, Kamb Mary L, Pandey Janardan P, Philen Rossanne M, Love Lori A, Miller Frederick W

Abstract excerpt

OBJECTIVE: To assess L-tryptophan (LT) dose, age, sex, and immunogenetic markers as possible risk or protective factors for the development of LT-associated eosinophilia-myalgia syndrome (EMS) and related clinical findings. METHODS: HLA-DRB1 and DQA1 allele typing and Gm/Km phenotyping were perfo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Outbreaks
Share to HLA-DQ alpha-Chains
Share to HLA-DQ Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-DR Antigens

Share to HLA-DRB1 Chains

Share to Immunoglobulin Gm Allotypes

Share to Molecular Epidemiology

Share to Tryptophan

Source

Open in PubMed Open full text

Identifiers

PMID: 19790128
DOI: 10.1002/art.24460
PMCID: PMC2761987

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19790128-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms.PMID 19790128Read ↗

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic PathwaySemantic proximity Read ↗

Pharmacogenetic characteristics of the eosinophilia-myalgia syndrome.Semantic proximity Read ↗

Association of Toll-like receptor 4 alleles with symptoms and sensitization to laboratory animals.Semantic proximity Read ↗

Enhancement of systemic and sputum granulocyte response to inhaled endotoxin in people with the GSTM1 null genotype.Semantic proximity Read ↗

The Kynurenine Pathway as a Convergent Hub Linking Toll-Like Receptor Signaling, Environmental Exposures, and Gut–Brain Axis Dysfunction in Neurodegenerative DiseasesSemantic proximity Read ↗

Eosinophilic disorders: Molecular pathogenesis, new classification, and modern therapySemantic proximity Read ↗

Clinical Potential of Eosinophil-Derived Neurotoxin in Asthma Management.Semantic proximity Read ↗

Genetic predisposition for the development of lamotrigine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.